Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Inventory Average (2013 - 2026)

Exelixis (EXEL) posted quarterly Inventory Average of $24.1 million for Q2 2026, up 2.22% year-over-year from $23.6 million in Q2 2025, and down 1.62% quarter-over-quarter from $24.5 million in Q1 2026.

Analysis

Exelixis (EXEL) Inventory Average (2013 - 2026) Analysis & Trends

Exelixis' Inventory Average history runs 14 years deep, the most recent figure standing at $24.1 million for Q2 2026.

  • In Q2 2026, Inventory Average rose 2.22% year-over-year to $24.1 million; the TTM figure through Apr 2026 stood at $24.1 million (up 2.22% YoY), while the FY2026 annual figure was $22.0 million, up 10.99% from the prior year.
  • Inventory Average for Q2 2026 stood at $24.1 million, down from $24.5 million in the prior quarter.
  • The five-year high for Inventory Average was $31.6 million in Q1 2023, with the low at $19.2 million in Q1 2024.
  • The 5-year median for Inventory Average is $24.5 million (2026), against an average of $25.4 million.
  • The sharpest annual moves came in 2022 and 2024: Inventory Average increased 23.62% in 2022, then sank 39.2% in 2024.
  • Exelixis' Inventory Average stood at $30.0 million in 2022, then decreased by 29.51% to $21.2 million in 2023, then declined by 1.59% to $20.8 million in 2024, then advanced by 22.24% to $25.4 million in 2025, then decreased by 5.1% to $24.1 million in 2026.
  • Business Quant data shows EXEL's Inventory Average at $24.1 million in Q2 2026, $24.5 million in Q1 2026, and $25.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.77 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 3.09 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 213.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 707.10 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 90.57 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 137.65 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 27.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 27.67 Mn
Apr 3, 2026 24.15 Mn
Jan 2, 2026 24.54 Mn
Oct 3, 2025 25.44 Mn
Jul 4, 2025 24.17 Mn
Apr 4, 2025 23.62 Mn
Jan 3, 2025 21.70 Mn
Sep 27, 2024 20.81 Mn
Jun 28, 2024 20.86 Mn
Mar 29, 2024 19.21 Mn
Dec 29, 2023 21.15 Mn
Sep 29, 2023 26.81 Mn
Jun 30, 2023 29.27 Mn
Mar 31, 2023 31.60 Mn
Dec 30, 2022 30.01 Mn
Sep 30, 2022 29.87 Mn
Jul 1, 2022 30.74 Mn
Apr 1, 2022 27.98 Mn
Dec 31, 2021 27.87 Mn
Oct 1, 2021 26.61 Mn